0001999124-24-000001.txt : 20241114 0001999124-24-000001.hdr.sgml : 20241114 20241113185046 ACCESSION NUMBER: 0001999124-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241114 DATE AS OF CHANGE: 20241113 EFFECTIVENESS DATE: 20241114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Healwell AI Inc. CENTRAL INDEX KEY: 0001999124 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-529360 FILM NUMBER: 241456220 BUSINESS ADDRESS: STREET 1: 4881 YONGE STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M2N 5X3 BUSINESS PHONE: 416-440-4040 MAIL ADDRESS: STREET 1: 4881 YONGE STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M2N 5X3 D 1 primary_doc.xml X0708 D LIVE 0001999124 Healwell AI Inc. 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 416-440-4040 ONTARIO, CANADA None None Corporation true Kingsley Ward 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 Director Hamed Shahbazi 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 Director Alexander Dobranowski 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 Executive Officer Director Erik Danudjaja 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 Director Bashar Al-Rehany 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 Director Anthony Lam 460 College Street Unit 301 Toronto A6 ONTARIO, CANADA M6G 1A1 Executive Officer Other Health Care Decline to Disclose 06b false 2024-11-01 false true true Acquisition pursuant to a SPA dated Oct 31/24 among HW, Mutuo Health Solutions Inc., and all of the shareholders of Mutuo, whereby HW acquired 51.1% of the shares of Mutuo on a fully-diluted basis from the Vendors in consideration for shares of HW. 0 66807 66807 0 CAD$93,073. Based on the Bank of Canada exchange rate of 0.7178 on November 1, 2024, which consists of shares of the issuer. false 1 0 0 0 false Healwell AI Inc. /s/Alexander Dobranowski Alexander Dobranowski Chief Executive Officer 2024-11-13